Archives
|
Entry
|
Blogger
|
Date
▴
|
Xconomist
|
Location
|
|
Alkermes Gets Alcohol Drug Rights From Cephalon
|
Luke Timmerman |
12/01/08 |
|
Boston
|
|
Biotech Survival Index: Boston Life Sciences Companies Brace for Long, Hard Winter
|
Luke Timmerman |
11/25/08 |
|
Boston
|
|
Amylin, Alkermes Shares Plunge On Possible FDA Delays
|
Luke Timmerman |
11/04/08 |
|
San Diego
|
|
Indevus Puts New Acromegaly Treatment Head-to-Head with Novartis Treatment in Phase 3 Trial
|
Ryan McBride |
09/30/08 |
|
Boston
|
|
Alkermes Makes Cuts, Eyegate Avoids Pokes, Codon Gets a Boost, & More Life Sciences News
|
Rebecca Zacks |
03/26/08 |
|
Boston
|
|
Alkermes Cuts Jobs After Lilly Deal Ends
|
Rebecca Zacks |
03/19/08 |
|
Boston
|
|
Exact Sciences Makes the List, Curis and Alkermes Get Dropped, Patent Reform Sparks Debate, & More Life Sciences News
|
Rebecca Zacks |
03/12/08 |
|
Boston
|
|
Curis, Alkermes Down on News of Failed Pharma Partnerships
|
Rebecca Zacks |
03/10/08 |
|
Boston
|
|
Biogen’s Busy Week, Alnylam’s Big Announcement, Targanta’s and Momenta’s Growing Executive Ranks, & More Life Sciences News
|
Rebecca Zacks |
03/05/08 |
|
Boston
|
|
Inverness Investors Go Back for Seconds, Alkermes Grabs a Slice of the GSK/Reliant Pie, Kalido Restocks the (Cash) Larder, and the Rest of Thanksgiving Week’s Deals
|
Rebecca Zacks |
11/26/07 |
|
Boston
|
|
Page 1 of
1 |
|
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.
© 2007-2008 Xconomy. All rights reserved.
Site designed by
Matthew Bouchard, produced by
Andrew Koyfman,
and powered by WordPress.
